Medtronic, Inc. (MDT)
-NYSE 51.53 
0.82(1.57%) May 22, 4:00PM EDT|After Hours
:
52.03 0.50 (0.98%) May 22, 6:22PM EDT
| Prev Close: | 52.35 |
|---|
| Open: | 51.97 |
|---|
| Bid: | 46.00 x 100 |
|---|
| Ask: | 51.84 x 200 |
|---|
| 1y Target Est: | 50.12 |
|---|
| Beta: | 1.02 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 51.11 - 52.60 |
|---|
| 52wk Range: | 35.67 - 53.83 |
|---|
| Volume: | 11,186,834 |
|---|
| Avg Vol (3m): | 4,319,010 |
|---|
| Market Cap: | 52.24B |
|---|
| P/E (ttm): | 15.24 |
|---|
| EPS (ttm): | 3.38 |
|---|
| Div & Yield: | 1.04 (2.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Featured on Yahoo! Finance
Headlines
- Medtronic Earnings Call Insights: Emerging Markets Analysis and CRM Businessat Wall St. Cheat Sheet(Wed, May 22)
- Medtronic's Defibrillator Sales Show A Pulse With Encouraging Resultsat Seeking Alpha(Wed, May 22)
- Final Glance: Medical Devices companiesAP(Wed, May 22)
- Medtronic Inc. (MDT): Today's Featured Health Care Laggardat TheStreet(Wed, May 22)
- Medtronic (MDT) Shares Cross 2% Yield Markat Forbes(Wed, May 22)
- Midday Glance: Medical Devices companiesAP(Wed, May 22)
- Medtronic Still Reporting Weak Growth, But A Relatively Rare Bargainat Investopedia(Wed, May 22)
- Analyst Moves: AZO, MDT, Tat Forbes(Wed, May 22)
- Early Glance: Medical Devices companiesAP(Wed, May 22)
- Boston Scientific’s Lotus Aortic Valve Shows Promise in Studyat Bloomberg(Wed, May 22)
- Medtronic Beats Earnings, Results StrongerZacks(Wed, May 22)
- Medtronic Beats on Both Top and Bottom Linesat Motley Fool(Wed, May 22)
- For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term ResultsThomson Reuters ONE(Wed, May 22)
- 4 Stocks Making Movesat Motley Fool(Tue, May 21)
- Medtronic Earnings Push Medical Device ETF HigherZacks(Tue, May 21)
Key Statistics
| Forward P/E (1 yr): | 13.42 |
|---|
| P/S (ttm): | 3.23 |
|---|
| Ex-Dividend Date: | 03-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Apr-13)
: | 3.69 |
|---|
| Quarterly EPS Est
(Apr-13)
: | 1.03 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 2.08 |
|---|
Business Summary
Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It provides products to diagnose, treat, and manage heart rhythm disorders and heart failure, including implantable cardiac pacemakers, implantable cardioverter defib...
View More